A Drosophila model of GDAP1 function reveals the involvement of insulin signalling in the mitochondria-dependent neuromuscular degeneration

Fecha de publicación:

Autores de IIS La Fe

  • Martina Palomino Schätzlein

    Autor

  • Marta Seco Cervera

    Autor

  • José Luis Garcia Gimenez

    Autor

  • Federico Vicente Pallardó Calatayud

    Autor

  • Máximo Ibo Galindo Orozco

    Autor

Participantes ajenos a IIS La Fe

  • López Del Amo V

Grupos

Abstract

Charcot-Marie-Tooth disease is a rare peripheral neuropathy for which there is no specific treatment. Some forms of Charcot-Marie-Tooth are due to mutations in the GDAP1 gene. A striking feature of mutations in GDAP1 is that they have a variable clinical manifestation, according to disease onset and progression, histology and mode of inheritance. Studies in cellular and animal models have revealed a role of GDAP1 in mitochondrial morphology and distribution, calcium homeostasis and oxidative stress. To get a better understanding of the disease mechanism we have generated models of over-expression and RNA interference of the Drosophila Gdapl gene. In order to get an overview about the changes that Gdapl mutations cause in our disease model, we have combined a comprehensive determination of the metabolic profile in the flies by nuclear magnetic resonance spectroscopy with gene expression analyses and biophysical tests. Our results revealed that both up- and down-regulation of Gdapl results in an early systemic inactivation of the insulin pathway before the onset of neuromuscular degeneration, followed by an accumulation of carbohydrates and an increase in the (3-oxidation of lipids. Our findings are in line with emerging reports of energy metabolism impairments linked to different types of neural pathologies caused by defective mitochondrial function, which is not surprising given the central role of mitochondria in the control of energy metabolism. The relationship of mitochondrial dynamics with metabolism during neurodegeneration opens new avenues to understand the cause of the disease, and for the discovery of new biomarkers and treatments. (C) 2017 Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0925-4439, 0006-3002

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE  ELSEVIER SCIENCE BV

Tipo:
Article
Páginas:
801-809
PubMed:
28065847
Factor de Impacto:
2,496 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 15

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • GDAP1; Charcot-Marie-Tooth; Mitochondria; Insulin

Proyectos y Estudios Clínicos

UNA APROXIMACIÓN ÓMICA AL DIAGNÓSTICO DE LA TUBERCULOSIS

PCIN-2013-041 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFICACIÓN DE DIANAS, LA EVALUACIÓN DE FÁRMACOS Y LA PERSONALIZACIÓN DE TRATAMIENTOS BASADA EN APROXIMACIONES METABOLÓMICAS

Investigador Principal: ANTONIO PINEDA LUCENA

SAF2014-53977-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015

RECALL. DESARROLLO DE PROTOTIPOS QUÍMICOS ORIENTADOS A LA GENERACIÓN DE TERAPIAS AVANZADAS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER

Investigador Principal: ANTONIO PINEDA LUCENA

RTC-2016-4803-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

Identificación de biotipos moleculares de cáncer de próstata como base de una medicina de precisón (BIOChiP).

Investigador Principal: LÓPEZ

PROMETEO/2016/103 . 2016

Cita

Compartir